Experimental cerebral infarction in the rat: utility of Gd-DOTA for MR imaging.
Nineteen rats presenting a very small (about 2-mm diameter), superficial cerebral infarction were studied with MR-imaging (1.89 Tesla) before and after injection of Gd-DOTA. Fifteen rats examined 1 or 2 hr, and 2, 3, 4, 5, 7, or 10 days after lesion induction, received 0.5 mmol Gd-DOTA/kg body weight. Four other rats presenting a 4-day-old lesion, received 0.1, 0.2, or 0.6 mmol Gd-DOTA/kg. Each rat underwent one imaging study comprising T2-weighted spin-echo (SE) images (3000/100) with subsequent injection of Gd-DOTA followed by 12 consecutive series of T1-weighted SE images (320/40), each taking 6 min. Using 0.5 mmol Gd-DOTA/kg, early (immediate) and long-lasting (more than 1 hour) visualization of lesions of varying age (1 hr to up to 10 days) was possible and at appropriate time intervals after injection, the visualization of the lesion was clearer and more complete than with T2-weighted images. Even in the rats studied with smaller doses of the contrast agent (0.1 or 0.2 mmol/kg), postcontrast T1-weighted images provided superior delineation of the lesions as compared to T2-weighted images.
Van de Vyver
F L
FL
Research Group for Biomedical NMR, University of Antwerp, Belgium.
Peersman
G V
GV
D000818:Animals; D002544:Cerebral Infarction / Q000175:diagnosis*; D004353:Drug Evaluation, Preclinical; D006571:Heterocyclic Compounds / Q000008:administration & dosage; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009942:Organometallic Compounds / Q000008:administration & dosage; D051381:Rats; D013997:Time Factors
D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate